Trastuzumab use at relapse after adjuvant trastuzumab therapy in HER2-positive breast cancer

Authors :: István Láng
F.Y. Feng
E. Carreras
Roberto Ivan Lopez
N. Al-Sakaff
Jenny C. Chang
Jacek Jassem
Vladimir Semiglazov
Richard Bell
Source :: Journal of Clinical Oncology. 29:575-575
Publication Year :: 2011
Publisher :: American Society of Clinical Oncology (ASCO), 2011.
Abstract: 575 Background: Trastuzumab (H) is the standard of care for patients with early and advanced HER2-positive breast cancer. It is therefore important to investigate the benefit of retreatment with H ...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Standard of care
business.industry
medicine.medical_treatment
education
medicine.disease
humanities
Breast cancer
Trastuzumab
Internal medicine
HER2 Positive Breast Cancer
Medicine
skin and connective tissue diseases
business
neoplasms
Adjuvant
medicine.drug

Tools